News

According to the company, 46.2% of patients demonstrated a 1- or 2-step improvement in the Diabetic Retinopathy Severity Scale (DRSS) at 40 weeks in the Axpaxli arm, compared to 0% in the control arm.

David Lubeck, MD, talks about the biggest surprises from ASCRS in the glaucoma space

BVI lenses feature a unique C-loop haptic design, known as “POD,” introduced to the market with the launch of the PODEYE hydrophobic IOL in Europe in 2012.

Analysis showed that patients with dry eye had “worse sleep quality than the healthy population."

Powers, whose father, sister, and brother are ophthalmologists, has held senior executive positions in strategic planning, marketing, and commercial and medical affairs at vision-focused companies.

Through free, virtual webinars, the companies are working to bring clinical education to eye care professionals around the world.

The 15th annual Congress on Controversies in Ophthalmology heads to Athens, Greece

Look beyond isolated treatment of the eye to address systemic factors.

Adam Muzychuk, MD, BSc, FRCSC discusses his presentation, "Outcomes of an ultra-low cylinder powered (0.90) toric versus non-toric in low astigmatic patients undergoing cataract surgery."

Lohith Shetty will lead marketing for the company, based in Kleinostheim, Germany

A brief analysis showed that ChatGPT 3.5 performed better.

The technology, which creates a 360-degree, instantaneous capsulotomy, appeared at the Eyecelerator event

According to the company, the feedback from the interactive meetings will provide guidance for the path to a PMA submission.

At the 2024 ASCRS Greg Kunst, CEO of Aurion Biotech relayed the latest news from Aurion and the company's work in cell therapies for corneal endothelial disease.

I-SCREEN will bring together 12 institutions across Europe, including Queen’s University Belfast

The program will use OCT images to identify and monitor AMD in its early stages.

Closed globe ocular injury often leads to macular pathology

Dr Nir Shoham-Hazon presented two papers detailing outcomes from the iTrack microcatheter at ASCRS in Boston

At this year's ASCRS meeting in Boston, Massachusetts, Ophthalmology Times Europe caught up with Eris Jordan, OD talked about the big plans the Boston-based startup has for the year ahead. Watch the full video to find out what's in store for the company and its novel cell therapy in Japan, Canada and the United States in 2024.

UPFs include fast food, energy drinks and soda, sweets such as chocolates and candies and much more.

The prosthesis bypasses the optic nerve and sends images directly to the patient's brain to create artificial sight.

David Eichenbaum, MD, discusses his experiences with aflibercept, faricimab.

At this year's ASCRS meeting, J. Morgan Micheletti, MD talked about myriad research projects he discussed at the meeting and also emphasized the importance of the Young Eye Surgeons (YES).

At this year's ASCRS meeting in Boston, Massachusetts, Pete England gave an update on ViaLase's development on the first femtosecond laser for the treatment of open-angle glaucoma.

Elizabeth Yeu, MD, discusses a corneal case report at ASCRS 2024

According to researchers, insights into the ocular microbiome could have implications beyond eye health.

Need to eliminate errors results in optimization of training of novice surgeons.